1. In the last 4 months, how many patients with atopic dermatitis have you treated with the following treatments? If you are unable to breakdown or report by condition then please provide numbers of patients treated with the listed drug regardless of indication or condition.
Answer (numbers of patients treated with the listed drug regardless of indication or condition):
|
Intervention
|
Number of patients
|
|
|
|
|
Dupixent (aka Dupilumab)
|
36
|
|
Rinvoq (aka upadacitinib)
|
0
|
|
Methotrexate
|
491
|
|
Ciclosporin
|
61
|
|
Azathioprine
|
72
|
|
Mycophenate mofetil
|
60
|
|
Tacrolimus
|
111
|
|
Pimecrolimus
|
16
|
|
Acitretin
|
124
|
|
Alitretinoin
|
10
|
|
Ultraviolet light therapy
|
150
|
2. How many adult atopic dermatitis patients have been treated in the last four months?
3. How many paediatric atopic dermatitis patients have been treated in the last four months?
Answer:
Regarding questions 2 and 3: Our data systems do not capture the level of required detail to say how many of these patients were treated and would require a manual case note audit of all patients within this period. In this instance it will cost more than the appropriate limit to consider your request. The appropriate limit is specified in regulations and for the Trust this is set at £450. This represents the estimated cost of one person spending 2½ working days in determining whether the Trust holds the information, and locating, retrieving and extracting the information. Consequently the Trust is not obliged under Section 12 of the Freedom of Information Act 2000 to respond to your request and we will not be processing your request further.
